Metabolic Syndrome in PCOS: Precursors and Interventions
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the metabolic effects of anti-androgens and oral
contraceptive pills (OCPs), compared with placebo, in the treatment of women with PCOS. We
hypothesized that controlling elevated androgen levels with either anti-androgens or OCPs
would produce improvement in metabolic markers in PCOS women and would reduce their long term
metabolic risk.
Phase:
N/A
Details
Lead Sponsor:
Northwestern University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)